Key Highlights
- Canton Strategic Holdings (NASDAQ:CNTN) reported third quarter Revenue of USD 3.1 million from network validation rewards and coin locking services, compared with none a year earlier, when it was still a biotechnology company.
- An unrealized loss of USD 54.6 million on Canton Coin holdings drove a net loss from continuing operations of USD 38.6 million, softened by a USD 15.3 million income tax benefit.
- Total net loss was USD 35.1 million against USD 2.1 million a year earlier, after USD 3.5 million of income from discontinued operations tied to the Gravitas sale.
- At September 30, 2026 the company held 3.83 billion Canton Coin with a Fair Value of USD 482.1 million, plus USD 26.9 million of cash and cash equivalents.
Coin Markdown Drives the Third Quarter Loss
Canton Strategic Holdings (NASDAQ:CNTN) filed its Quarterly Report on November 16, 2026 for the period ended September 30. Revenue was USD 3.1 million, split almost evenly between network validation revenue of USD 1.5 million and other revenue of USD 1.5 million, mostly from locking services. General and administrative expense rose 49% to USD 2.7 million on higher pay, insurance and digital asset costs. The unrealized loss on digital Assets of USD 54.6 million pushed the pretax loss to USD 53.9 million. After a USD 15.3 million tax benefit, the continuing loss was USD 38.6 million. Interest income rose to USD 0.4 million, helped by interest on the Gravitas note.
From Biotechnology to a Canton Coin Treasury
From 2022 to late 2025 the company developed therapies for inflammatory and immunologic conditions. In November 2025 it shifted to holding and deploying Canton Coin and running node infrastructure on the Canton Network, funded by private placements and a January 2026 offering. On July 17, 2026 it sold its biotechnology Subsidiary Gravitas for a USD 3.5 million Promissory Note bearing 15% payment-in-kind interest, plus up to USD 3.0 million of milestone payments. It kept the bispecific antibody oncology program, and the buyer prepaid USD 1.1 million of the note in October. The sale produced a gain of USD 3.7 million.
Super Validator Weight and a USD 285.9 Million Funding Window
Active Super Validator weight rose to 6.5 during the quarter, with another 8.5 recorded but not yet eligible for minting. The company expects total weight to reach 15.0 by the first quarter of 2028 if it meets milestones. The holding of 3.83 billion coins carries a cost basis of USD 597.6 million, above the USD 482.1 million fair value. Nine-month remeasurement losses on coin holdings were USD 93.4 million. About USD 285.9 million remains available under the March 2026 at-the-market agreement, and a share repurchase program approved in June 2026 sets no obligation to buy.
Where Things Stand
A USD 54.6 million unrealized loss on Canton Coin holdings explains the quarter. Canton Strategic Holdings (NASDAQ:CNTN) earned USD 3.1 million of revenue against USD 2.7 million of general and administrative expense, so, calculated before interest income, operations were close to break-even before the markdown, which carried the net loss to USD 35.1 million. Coin fair value of USD 482.1 million sits below the USD 597.6 million cost basis. Next markers are further Super Validator weight releases, locking service Demand and any use of the funding agreement.


_11_18_2026_14_48_04_195267.jpg)



Please wait processing your request...